Literature DB >> 436048

Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.

D R Wilson, G Pylypchuk, U Ehrig.   

Abstract

Normocalciuric and hypercalciuric patients with idiopathic recurrent calcium nephrolithiasis were compared with healthy individuals without such a history to examine the factors that predispose normocalciuric patients to stone formation. The urine calcium excretion rate was higher in the normocalciuric patients than in the control subjects (227 v. 183 mg/24 h; P less than 0.01), but the urine calcium concentration was not significantly different. The urine magnesium and citrate excretion rates and concentrations were lower in the normocalciuric patients than in the control subjects (P less than 0.001), while the urine uric acid and oxalate excretion rates and concentrations and the urine saturation with brushite (CaHPO4-2H2O) were not significantly different. These results suggest the importance of slight increases in the urine calcium excretion rate together with decreased urine magnesium and citrate excretion rates in normocalciuric persons with recurrent calcium stone formation. The urine of the hypercalciuric patients was more highly saturated with brushite than the urine of the normocalciuric patients and the control subjects, and the excretion rates of uric acid and oxalate were increased in the hypercalciuric patients. The hypercalciuric patients had a higher urine creatinine excretion rate than the normocalciuric patients and a higher daily urine volume than the control subjects, which suggests that differences in lean body mass or fluid and food intake, or both, may be important determinants of these differences in crystalloid excretion. As in the normocalciuric patients, the urine citrate excretion rate and concentration were decreased in the hypercalciuric patients compared with the control subjects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436048      PMCID: PMC1819166     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  9 in total

1.  Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.

Authors:  F L Coe
Journal:  Ann Intern Med       Date:  1977-10       Impact factor: 25.391

Review 2.  Inhibitors and promoters of stone formation.

Authors:  H Fleisch
Journal:  Kidney Int       Date:  1978-05       Impact factor: 10.612

3.  Urinary excretion of calcium and magnesium in patients with calcium-containing renal stones.

Authors:  R A Evans; M A Forbes; R A Sutton; L Watson
Journal:  Lancet       Date:  1967-11-04       Impact factor: 79.321

4.  Magnesium-calcium ratio in urine of patients with renal stones.

Authors:  D G Oreopoulos; M A Soyannwo; M G McGeown
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

5.  Dissolution and growth of calcium oxalate monohydrate. I. Effect of magnesium and pH.

Authors:  J F Desmars; R Tawashi
Journal:  Biochim Biophys Acta       Date:  1973-07-28

6.  The distribution of urinary calcium excretions in normal persons and stone-formers.

Authors:  W G Robertson; D B Morgan
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

7.  Urinary supersaturation with calcium oxalate before and during orthophosphate therapy.

Authors:  D C Burdette; W C Thomas; B Finlayson
Journal:  J Urol       Date:  1976-04       Impact factor: 7.450

8.  Nomograms for the estimation of the saturation of urine with calcium oxalate, calcium phosphate, magnesium ammonium phosphate, uric acid, sodium acid urate, ammonium acid urate and cystine.

Authors:  R W Marshall; W G Robertson
Journal:  Clin Chim Acta       Date:  1976-10-15       Impact factor: 3.786

9.  Renal calculi.

Authors:  E R Yendt
Journal:  Can Med Assoc J       Date:  1970-03-14       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.